No dinosaurs were harmed in the making of this vaccine.
Stephanie Sutton |
Some of you may have spotted “big bad” pharma’s cameo in the new Jurassic World: Fallen Kingdom movie. It’s not central to the plot; just a one-line mention of a (shifty) biopharma CEO who wants to acquire a dinosaur to explore new bioactives. Unfortunately, the movie doesn’t go into further details about how dinosaurs could influence modern medicine – or the many other burning questions I’m sure we all have. How does one perform tests on a dinosaur? Is a special facility required? Would the resulting “dinomab” be suitable for next generation bioprocessing techniques? Is there a disaster recovery plan in case the dinosaur rampages? (Of course not). And how on earth would regulators react to dinosaur-derived medicines?
Clearly, we shouldn’t read too much into pharma’s frequent portrayal as the fictional villain –any organization that performs experiments is juicy inspiration for a storyline. That said, Hollywood does like to tap into popular opinion and, right now, the general population has a low opinion of pharma. In the US, Edelman’s annual Trust Barometer survey shows that pharma companies saw a notable drop in trust between 2016 and 2017 – from 51 percent to 38 percent. You can read more on here.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine